Anemia in Chronic Kidney Disease: Improved Patient Outcomes Needed STAT!

Anemia in Chronic Kidney Disease: Improved Patient Outcomes Needed STAT!

Anemia in Chronic Kidney Disease: Improved Patient Outcomes Needed STAT!
RestartResume

The prevalence of anemia in CKD increases with disease stage, comorbidities, and patient age. Be sure you’re diagnosing and treating patients STAT!

Available credits: 0.50

Time to complete: 30 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Clinicians have a critical need for up-to-date knowledge related to anemia in CKD. Provide better care for your patients by learning about advances in our understanding of the pathophysiology of the disease, ways to fill the unmet needs of treatment with erythropoiesis-stimulating agents (ESAs), and the status of potential new therapies.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Rajeev Raghavan, MD, M.Ed, FASN

    Clinical Professor of Medicine
    University of Houston School of Medicine
    Houston, TX

    Consulting Fees: Bayer, GlaxoSmithKline

    Charles P. Vega, MD
    Clinical Professor, Family Medicine
    Associate Dean, School of Medicine
    University of California, Irvine
    Orange, CA

    Consulting Fees: GlaxoSmithKline, Johnson & Johnson

    Reviewers/Content Planners/Authors:

    • Cindy Davidson has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Keith Johnson has nothing to disclose.
    • Libby Lurwick has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Jay Runyon has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Discuss the challenges surrounding the timely assessment and appropriate treatment of anemia of chronic kidney disease (CKD)
    • Describe the multifactorial mechanisms of anemia of CKD
    • Understand the mechanism of action of HIF-PHIs and data about their safety and efficacy from recent clinical trials
  • Target Audience

    This activity is designed to meet the educational needs of nephrologists, primary care physicians, cardiologists, and endocrinologists.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 0.5 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until 9/30/2023. PAs should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Our ultimate goal is to improve the care being delivered to patients, and our high quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum.

  • Commercial Support

    This activity is supported by an independent educational grant from GlaxoSmithKline, LLC.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments

Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free